Canid

New York, United States Founded: 2020 • Age: 6 yrs
Vaccination management solutions for childrens health are provided.

About Canid

Canid is a company based in New York (United States) founded in 2020 by Pedro Sanchez De Lozada. It operates as a HealthTech and Managed Services. Canid has raised $11.5 million across 2 funding rounds from investors including FJ Labs, seedToB and Alumni Ventures. Canid offers products and services including Vaccine Management System, Inventory Automation, and Billing Support. Canid operates in a competitive market with competitors including FlexIG, VacTrack, MittVaccin, ImmunifyMe and AsepsisLife, among others.

  • Headquarter New York, United States
  • Founders Pedro Sanchez De Lozada
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website canid.io
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $11.5M (USD)

    in 2 rounds

  • Latest Funding Round
    $10M (USD), Series A

    Jun 2025

  • Investors
    FJ Labs

    & 6 more

Products & Services of Canid

Canid offers a comprehensive portfolio of products and services, including Vaccine Management System, Inventory Automation, and Billing Support.

Vaccine Management System
Healthcare Technology

Vaccine operations are managed for pediatric practices efficiently.

Inventory Automation
Healthcare Technology

Vaccine inventory is tracked and reordered automatically always.

Billing Support
Healthcare Services

Vaccine billing is handled to ensure full payment.

Funding Insights of Canid

Canid has successfully raised a total of $11.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $11.5M
  • Total Rounds 2
  • Last Round Series A β€” $10M
  • First Round $1.5M

    (Sep 2023)

  • Investors Count 7

All 2 funding rounds of Canid with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2025$10MSeries A–Telescope Partners
Sep 2023$1.5MSeed–seedToB
Valuation history

7 investors in total: 7 institutional.

Investors in Canid

Canid has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include FJ Labs, seedToB and Alumni Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm focused on marketplaces, gaming, web3, fintech, and multiple sectors
2007fjlabs.comNew York, United States
Venture capital investing and portfolio management services for accredited investors.
–av.vc-
Early-stage technology companies are funded by this venture capital firm.
–i2bf.comBeverly Hills, United States
MKT1 is engaged in providing marketing resources for B2B startups.
2020mkt1.co-
Telescope is engaged in early growth investments for enterprise software.
–telescopepartners.comSan Francisco, United States
Seed-stage VC micro firm investing in the US
–brooklynbridge.vcBrooklyn, United States
Invests in Seed and Series A AI healthcare startups with network and tactical support.
2020seedtob.comCanada
Premium access

Investor details for Canid

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Canid

9 people are tracked at Canid (4 in leadership, 5 in team).

NameRoleGroup
Pedro Sanchez De Lozada
Founder & CEOLeadership
Juliana Muñoz
Chief Operating OfficerLeadership
Emilio González
Head Of EngineeringLeadership
Shawn Saunders
Head Of Enterprise Sales & PartnershipsLeadership
Facundo Gait
Full-stack DeveloperTeam
Daniel Alberto Stocco
Full-stack DeveloperTeam
Ignacio Agustin Morchio 🇦🇷
Software EngineerTeam
Trevor L.
Customer SuccessTeam
Rodolfo Emilio Errecart
Desarrollador De Back-endTeam
Premium access

Complete people profiles for Canid

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Canid

3 dated milestones of Canid across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Canid is founded.
  2. Funding First funding round of $1.5M.
  3. Funding Latest funding round, Series A, of $10.0M.

Competitors of Canid

Canid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as FlexIG, VacTrack, MittVaccin, ImmunifyMe and AsepsisLife, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
flexig.com2015–––
Mobile app for tracking injections, health data, and treatment reminders.
vactrack.com2020London, United Kingdom––
Vaccination appointments are booked through a mobile application.
mittvaccin.se2012Sweden––
Mobile app for vaccination record monitoring and reminders is provided.
immunifyme.com2019Luxembourg–1
Mobile application to track child vaccination records
asepsislife.com2014Bengaluru, India––
Provides a mobile app for vaccination tracking and evidence-based healthcare content.
Premium access

Detailed competitors of Canid

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Canid

The website of Canid (canid.io) receives about 2.8K visits a month.

  • Monthly visits
    2.8K

    ▼ 15.8% vs previous month

Latest news on Canid

Premium access

Complete news archive for Canid

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Canid

10 companies that operate in the same segment as Canid (Health Monitoring & Wearables), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,660
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
Internet first brand offering wearable breast pumps
2013London, England, United KingdomUSD 157.63 M––
Metabolic health is tracked via devices and fitness platforms.
2019Bengaluru, Karnataka, IndiaUSD 163.28 MUSD 65.48 M274
Health-tracking smart rings and biosensors are developed for biometric monitoring.
2013Oulu, North Ostrobothnia, FinlandUSD 1.32 B––
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
AI-based mobile app tracks and predicts menstrual cycles.
2015London, England, United KingdomUSD 269 M––
Smartphone-enabled glucometers and diabetes management apps are provided.
2015Delhi, Delhi, IndiaUSD 50.83 MUSD 2.74 M142
Provider of a fertility tracking app that doubles as birth control
2013Stockholm, SwedenUSD 99.5 M––
Diabetes management is enabled via glucose meters and mobile apps.
2010Palo Alto, California, United StatesUSD 201 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Canid

Canid was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Canid is headquartered in New York, United States. It is registered at New York, New York, United States.

Pedro Sanchez De Lozada is the current CEO of Canid. They have also founded this company.

Canid is a funded company, having raised a total of $11.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Sep 2023.

Vaccine operations are streamlined for small pediatric practices by Canid. Comprehensive support is provided in inventory management, purchasing, billing, and registry uploads. Automation of workflows is enabled to reduce manual tasks. Better care is facilitated through identifying under-vaccinated children and running outreach campaigns. The healthcare sector, specifically pediatric care, is targeted with solutions designed to ensure financial sustainability. Feedback from practices is incorporated to evolve the product continuously.

Canid's top competitors include MittVaccin, ImmunifyMe and VacTrack.

Canid offers Vaccine Management System, Inventory Automation, and Billing Support.

Canid has 7 investors. Key investors include FJ Labs, seedToB, Alumni Ventures, I2BF Global Ventures, and MKT1.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available